A Novel Heterologous Prime-boost Strategy Using RUTI Vaccine to Improve the Bacillus Calmette-Guérin Response in Non-muscle-invasive Bladder Cancer Patients: Phase 1 RUTIVAC-1 Trial.
- DOI
- 10.1016/j.eururo.2025.08.014
- Published
- 2026 Feb
- Container
- European urology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.eururo.2025.08.014,
title = {A Novel Heterologous Prime-boost Strategy Using RUTI Vaccine to Improve the Bacillus Calmette-Guérin Response in Non-muscle-invasive Bladder Cancer Patients: Phase 1 RUTIVAC-1 Trial.},
author = {Buisan O and Servian P and Pedreño-Lopez S and Pagès J and Urrea V and Martínez R and Garcia E and Cardona PJ and Vilaplana C and Amat M and Areal J and Bellmunt J and Clotet B and Cabrera C},
year = {2026},
journal = {European urology},
doi = {10.1016/j.eururo.2025.08.014},
url = {https://doi.org/10.1016/j.eururo.2025.08.014}
}RIS
TY - JOUR TI - A Novel Heterologous Prime-boost Strategy Using RUTI Vaccine to Improve the Bacillus Calmette-Guérin Response in Non-muscle-invasive Bladder Cancer Patients: Phase 1 RUTIVAC-1 Trial. AU - Buisan O AU - Servian P AU - Pedreño-Lopez S AU - Pagès J AU - Urrea V AU - Martínez R AU - Garcia E AU - Cardona PJ AU - Vilaplana C AU - Amat M AU - Areal J AU - Bellmunt J AU - Clotet B AU - Cabrera C PY - 2026 JO - European urology DO - 10.1016/j.eururo.2025.08.014 UR - https://doi.org/10.1016/j.eururo.2025.08.014 ER -
APA
O, B., P, S., S, P., J, P., V, U., R, M., E, G., PJ, C., C, V., M, A., J, A., J, B., B, C., & C, C. (2026). A Novel Heterologous Prime-boost Strategy Using RUTI Vaccine to Improve the Bacillus Calmette-Guérin Response in Non-muscle-invasive Bladder Cancer Patients: Phase 1 RUTIVAC-1 Trial.. European urology. https://doi.org/10.1016/j.eururo.2025.08.014
Source records
- pubmed · retrieved 2026-09-25T20:46:48.831Z